CYYNF (Cynata Therapeutics) Accounts Payable: $0.57 Mil (As of Dec. 2025)


What is Cynata Therapeutics Accounts Payable?

Cynata Therapeutics CYYNF -55.56% Accounts Payable is $0.57 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Cynata Therapeutics's Accounts Payable for the quarter that ended in Dec. 2025 was $0.57 Mil.

Cynata Therapeutics's quarterly Accounts Payable declined from Dec. 2024 ($0.72 Mil) to Jun. 2025 ($0.26 Mil) but then increased from Jun. 2025 ($0.26 Mil) to Dec. 2025 ($0.57 Mil).

Cynata Therapeutics's annual Accounts Payable declined from Jun. 2023 ($0.88 Mil) to Jun. 2024 ($0.29 Mil) and declined from Jun. 2024 ($0.29 Mil) to Jun. 2025 ($0.26 Mil).

Cynata Therapeutics Accounts Payable Related Terms

Cynata Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Cynata Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cynata Therapeutics Accounts Payable Chart

Cynata Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 1.11 0.88 0.29 0.26

Cynata Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.29 0.72 0.26 0.57

Cynata Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.57 Mil mean?
Cynata Therapeutics (CYYNF) has a Accounts Payable of $0.57 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cynata Therapeutics and its competitors.
Is Cynata Therapeutics' Accounts Payable too high?
Cynata Therapeutics' current Accounts Payable is $0.57 Mil.
How does Cynata Therapeutics' Accounts Payable compare to VRTX and REGN?
Cynata Therapeutics' Accounts Payable of $0.57 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cynata Therapeutics and its competitors. Cynata Therapeutics's current Accounts Payable is $0.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cynata Therapeutics stock overvalued right now?
Cynata Therapeutics (CYYNF) has a current Accounts Payable of $0.57 Mil. The current Accounts Payable is $0.57 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Cynata Therapeutics (CYYNF), the current Accounts Payable is $0.57 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cynata Therapeutics Business Description

Other Exchanges 51S:GermanyCYP:Australia
Address 100 Cubitt Street, Level 3, Cremorne, VIC, AUS, 3121
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus manufacturing platform. There are currently three active clinical trials taking place using Cymerus technology, which are attempting to treat osteoarthritis and others.